These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9757054)

  • 1. The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy.
    Gerber K; Filakovszky J; Halasz P; Bagdy G
    Brain Res; 1998 Oct; 807(1-2):243-5. PubMed ID: 9757054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model.
    Filakovszky J; Gerber K; Bagdy G
    Neurosci Lett; 1999 Feb; 261(1-2):89-92. PubMed ID: 10081934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
    Jakus R; Graf M; Juhasz G; Gerber K; Levay G; Halasz P; Bagdy G
    Exp Neurol; 2003 Dec; 184(2):964-72. PubMed ID: 14769389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of serotonin syndrome by 8-OH DPAT in Cryptotis parva.
    Darmani NA; Zhao W
    Physiol Behav; 1998 Nov; 65(2):327-31. PubMed ID: 9855483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy.
    Jakus R; Graf M; Ando RD; Balogh B; Gacsalyi I; Levay G; Kantor S; Bagdy G
    Brain Res; 2004 May; 1008(2):236-44. PubMed ID: 15145761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep/waking effects following intrathecal administration of the 5-HT(1A) Agonist 8-OH-DPAT alone and in combination with the putative 5-HT(1A) antagonist NAN-190 in rats.
    Bjørkum AA; Ursin R
    Brain Res Bull; 1996; 39(6):373-9. PubMed ID: 9138747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-HT1A receptor agonist and antagonist on anxiety in intact and ovariectomized female rats.
    Fedotova JO; Hartmann G; Lénárd L; Sapronov NS
    Acta Physiol Hung; 2004; 91(3-4):175-84. PubMed ID: 16438111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
    Ahlers ST; Weissman BA; Barrett JE
    J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-OH-DPAT prevents morphine-induced apoptosis in rat dorsal raphe nucleus: a possible mechanism for attenuating morphine tolerance.
    Charkhpour M; Nayebi AR; Doustar Y; Hassanzadeh K
    Anesth Analg; 2010 Nov; 111(5):1316-21. PubMed ID: 20736434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis.
    Fujii T; Yoshizawa M; Nakai K; Fujimoto K; Suzuki T; Kawashima K
    Brain Res; 1997 Jul; 761(2):244-9. PubMed ID: 9252022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors.
    Ebenezer IS; Arkle MJ; Tite RM
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):269-72. PubMed ID: 17609739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS; Matuszewich L; Hull EM
    Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the putative 5-HT1A receptor antagonist NAN-190 on free feeding and on feeding induced by the 5-HT1A receptor agonist 8-OH-DPAT in the rat.
    Williams AR; Dourish CT
    Eur J Pharmacol; 1992 Aug; 219(1):105-12. PubMed ID: 1397037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT1A receptors in passive avoidance learning in intact and ovariectomized female rats.
    Fedotova JO; Hartmann G; Lénárd L; Sapronov NS
    Acta Physiol Hung; 2004; 91(3-4):185-96. PubMed ID: 16438112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central 5-HT1A receptors inhibit adrenocortical secretion.
    Welch JE; Farrar GE; Dunn AJ; Saphier D
    Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
    Zuideveld KP; Treijtel N; Maas HJ; Gubbens-Stibbe JM; Peletier LA; van Der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Jan; 300(1):330-8. PubMed ID: 11752133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.